<DOC>
	<DOCNO>NCT00009815</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one chemotherapy drug may kill tumor cell . PURPOSE : Phase I trial study effectiveness combination chemotherapy treat patient advance solid tumor .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Advanced Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose etoposide combine fixed- dose fluorouracil-uracil plus leucovorin calcium patient advance solid tumor . II . Determine possible side effect toxicity regimen patient . OUTLINE : This dose escalation study etoposide . Patients receive oral etoposide daily day 1-10 oral fluorouracil-uracil plus oral leucovorin calcium twice day day 1-21 . Treatment repeat every 28 day maximum 6 course absence unacceptable toxicity disease progression . Cohorts 3-6 patient receive escalate dos etoposide maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 6 patient experience dose-limiting toxicity . Patients follow 2 month periodically survival . PROJECTED ACCRUAL : Approximately 25-30 patient accrue study .</detailed_description>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Tegafur</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm solid tumor curative effective therapy available No symptomatic uncontrolled brain leptomeningeal metastasis CT scan require clinical suspicion CNS metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great upper limit normal ( ULN ) AST great 1.5 time ULN No acute hepatitis Renal : Not specify Cardiovascular : No unstable cardiac disease No history cardiac arrhythmia ( treat untreated ) No new onset crescendo rest angina ( stable exertional angina allow ) Pulmonary : Not specify Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception least 1 week prior , , least 2 week study No know hypersensitivity fluorouraciluracil leucovorin calcium No grade 2 great nausea/vomiting diarrhea No significant neurological psychiatric condition , include psychotic disorder , dementia , seizures No active serious infection septicemia No severe gastrointestinal bleeding No serious illness significant medical condition would preclude study No psychological , familial , sociological condition would preclude study PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent immunotherapy Chemotherapy : At least 3 week since prior chemotherapy ( 6 week mitomycin nitrosoureas ) recover No 1 prior chemotherapy regimen Prior fluorouracil taxanes allow Prior parenteral etoposide allow Endocrine therapy : No concurrent anticancer hormonal agent Radiotherapy : At least 3 week since prior radiotherapy recover Prior radiotherapy brain metastasis allow stable neurological status achieve within 4 week treatment No concurrent radiotherapy except palliation bone brain metastasis pathological fracture know lytic disease Surgery : Not specify Other : At least 3 week since prior investigational drug recover No concurrent anticancer drug No concurrent investigational therapy No concurrent halogenated antiviral agent lodenosine , fialuridine , clevudine , emtricitabine , sorivudine No concurrent antiarrhythmic medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>